At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4583 Monkeypox Concept
Not Yet Opened 01-14 16:00:00 EST
1,719.74
+30.70
+1.82%
High1,721.05Low1,684.74Vol20.69M
Open1,688.98D1 Closing1,689.03Amplitude2.15%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O1.02BT/O Rate--Tradable Shares0.00
P/B4.171972ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Emergent BioSolutions outlines transformation and financial guidance at conference
TIPRANKS  ·  06:28
Emergent BioSolutions outlines transformation and financial guidance at conference
Gilead Sciences Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
Dow Jones  ·  05:36
Gilead Sciences Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
FDA Approves New Carrying Case for Emergent BioSolutions' OTC NARCAN Nasal Spray
Reuters  ·  01-14 21:01
FDA Approves New Carrying Case for Emergent BioSolutions' OTC NARCAN Nasal Spray
Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for Narcan® Nasal Spray to Be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness
THOMSON REUTERS  ·  01-14 21:00
Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for Narcan® Nasal Spray to Be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness
Quest Diagnostics Inc. Stock Outperforms Competitors On Strong Trading Day
Dow Jones  ·  01-14 06:08
Quest Diagnostics Inc. Stock Outperforms Competitors On Strong Trading Day
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and GRAIL Inc (GRAL)
TIPRANKS  ·  01-14 03:10
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and GRAIL Inc (GRAL)
Bernstein Remains a Buy on Gilead Sciences (GILD)
TIPRANKS  ·  01-14 02:16
Bernstein Remains a Buy on Gilead Sciences (GILD)
Gilead price target lowered to $150 from $151 at Morgan Stanley
TIPRANKS  ·  01-13 21:39
Gilead price target lowered to $150 from $151 at Morgan Stanley
FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms
Reuters  ·  01-13 20:50
FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms
H.C. Wainwright Remains a Buy on Emergent Biosolutions (EBS)
TIPRANKS  ·  01-13 19:36
H.C. Wainwright Remains a Buy on Emergent Biosolutions (EBS)
Gilead Sciences (GILD) Receives a Buy from Citi
TIPRANKS  ·  01-13 19:18
Gilead Sciences (GILD) Receives a Buy from Citi
BRIEF-Quest Diagnostics Long-Term Outlook Beyond 2025 4%-5% Revenue Cagr, 7%-9% Adjusted EPS Cagr
Reuters  ·  01-13 07:12
BRIEF-Quest Diagnostics Long-Term Outlook Beyond 2025 4%-5% Revenue Cagr, 7%-9% Adjusted EPS Cagr
Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
Dow Jones  ·  01-13 06:26
Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
Quest Diagnostics targets about $1.0B in dividend over 2025-2027 period
TIPRANKS  ·  01-13 06:00
Quest Diagnostics targets about $1.0B in dividend over 2025-2027 period
Quest Diagnostics Highlights Growth Strategy at Healthcare Conference
TIPRANKS  ·  01-13 05:59
Quest Diagnostics Highlights Growth Strategy at Healthcare Conference
Quest Diagnostics: Long-Term Outlook Beyond 2025: 4%-5% REV Cagr, 7%-9% Adj EPS Cagr
THOMSON REUTERS  ·  01-13 05:40
Quest Diagnostics: Long-Term Outlook Beyond 2025: 4%-5% REV Cagr, 7%-9% Adj EPS Cagr
Quest Diagnostics Releases Transcript from J.P. Morgan Healthcare Conference Presentation
Reuters  ·  01-13 05:38
Quest Diagnostics Releases Transcript from J.P. Morgan Healthcare Conference Presentation
GeoVax Labs Inc - Announces 1-for-25 Reverse Stock Split - SEC Filing
THOMSON REUTERS  ·  01-13 05:38
GeoVax Labs Inc - Announces 1-for-25 Reverse Stock Split - SEC Filing
GeoVax Labs Enacts 1-for-25 Reverse Stock Split
Reuters  ·  01-13 05:32
GeoVax Labs Enacts 1-for-25 Reverse Stock Split
Gilead Sciences Shares Rise in Volume Spike, Last up 1.6% at $122.99
THOMSON REUTERS  ·  01-13 03:44
Gilead Sciences Shares Rise in Volume Spike, Last up 1.6% at $122.99

Introduction

Company Name.
BK4583
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--